Life Tech has gained global distribution rights to the system, which is a compact multiplex analyzer that rapidly detects 50 different analytes simultaneously on a single sample.
Garvan Institute will evaluate HealthLinx's prostate cancer biomarkers under one deal, while CPC Clinical Research will liaise with the FDA for HealthLinx's OvPlex test under a separate agreement.
RBM acquired biomarker-related IP for Alzheimer's disease and other central nervous system conditions.
Consumables sales were up 53 percent during the quarter to an all-time high of $15 million.
The firm has received pre-IDE evaluations from the FDA for BreastGeneDx and is currently looking for partners to help it during the next stage of assay validation.
The Prevail patient registry will be used to analyze primary care ambulatory practices for risk factor management of patients who have a high risk of converting to type 2 diabetes.
Rady Children's Institute for Genomic Medicine and Deloitte are looking into the use of drones to transport samples for testing.
Direct-to-consumer genetic testing firm 23andMe is laying off about 100 people.
Researchers from Northwestern University examined dust for antibiotic-resistance genes, New Scientist reports.
In Science this week: researchers present a computational method for predicting cellular differentiation state from single-cell RNA sequencing data, and more.